Serina Therapeutics Inc is a forward-thinking biotechnology company focused on developing innovative therapies for unmet medical needs, particularly in oncology and neurology. Leveraging its proprietary polymer-based drug delivery platform, Serina enhances therapeutic efficacy to improve patient outcomes. With a robust pipeline of product candidates, the company is well-positioned for sustainable growth in the biopharmaceutical sector. Its dedication to advanced technology and strategic collaborations reflects its commitment to transforming healthcare solutions and creating value for investors.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

601 GENOME WAY, HUNTSVILLE, AL, UNITED STATES, 35806

December

$24.4 Million

-$23.9 Million

0.0

-1.91

$0.00

0.0%

0.098